Alliant Energy (NASDAQ:LNT – Get Free Report) had its price target lowered by equities researchers at LADENBURG THALM/SH SH from $48.50 to $48.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm presently has a “neutral” rating on the stock. LADENBURG THALM/SH SH’s price target points to a potential […]
LADENBURG THALM/SH SH began coverage on shares of Inuvo (NYSE:INUV – Free Report) in a research report report published on Tuesday morning, Benzinga reports. The brokerage issued a buy rating and a $1.00 target price on the stock. Separately, StockNews.com initiated coverage on Inuvo in a research note on Friday, March 29th. They set a […]
Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report) was upgraded by analysts at LADENBURG THALM/SH SH from a “neutral” rating to a “buy” rating in a report released on Tuesday, Briefing.com reports. The firm currently has a $8.00 target price on the stock. LADENBURG THALM/SH SH’s target price would suggest a potential upside of 143.16% […]
LADENBURG THALM/SH SH downgraded shares of OGE Energy (NYSE:OGE – Free Report) from a buy rating to a neutral rating in a report published on Tuesday morning, Marketbeat.com reports. They currently have $34.00 target price on the utilities provider’s stock, down from their previous target price of $36.00. OGE has been the topic of a […]
LADENBURG THALM/SH SH assumed coverage on shares of Sonnet BioTherapeutics (NASDAQ:SONN – Free Report) in a report released on Monday morning, Benzinga reports. The firm issued a buy rating on the stock. Separately, Chardan Capital cut their price objective on Sonnet BioTherapeutics from $308.00 to $264.00 and set a buy rating for the company in […]